Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $214,402 (100.0% shares, 0.0% debt)

Holdings (8)

— EYEPOINT PHARMACEUTICALS INC 30.3%

Value ($000) $64,959 Shares 41,909,219 Est. Cost $1.64 Unrealized —

— REVANCE THERAPEUTICS INC 25.3%

Value ($000) $54,241 Shares 3,342,047 Est. Cost $31.50 Unrealized —

AXGN AXOGEN INC 20.3%

Value ($000) $43,473 Shares 2,429,999 Est. Cost $4.01 Unrealized +268.8%

— VENUS CONCEPT INC 15.4%

Value ($000) $32,984 Shares 7,017,856 Est. Cost $4.70 Unrealized —

TELA TELA BIO INC 4.6%

Value ($000) $9,962 Shares 769,231 Est. Cost $12.23 Unrealized 0.0%

MNOV MEDICINOVA INC 3.5%

Value ($000) $7,531 Shares 1,117,355 Est. Cost $2.95 Unrealized +155.0%

— ENDOLOGIX INC 0.3%

Value ($000) $717 Shares 125,747 Est. Cost $11.05 Unrealized —

— CATALYST BIOSCIENCES INC 0.2%

Value ($000) $535 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	EYEPOINT PHARMACEUTICALS INC	41,909,219	$64,959	30.3%	$1.64	—	COM	30233G100
—	REVANCE THERAPEUTICS INC	3,342,047	$54,241	25.3%	$31.50	—	COM	761330109
AXGN	AXOGEN INC	2,429,999	$43,473	20.3%	$4.01	+268.8%	COM	05463X106
—	VENUS CONCEPT INC	7,017,856	$32,984	15.4%	$4.70	—	COM	92332W105
TELA	TELA BIO INC	769,231	$9,962	4.6%	$12.23	0.0%	COM	872381108
MNOV	MEDICINOVA INC	1,117,355	$7,531	3.5%	$2.95	+155.0%	COM NEW	58468P206
—	ENDOLOGIX INC	125,747	$717	0.3%	$11.05	—	COM NEW	29266S304
—	CATALYST BIOSCIENCES INC	78,622	$535	0.2%	$7.36	—	COM NEW	14888D208